Vesicular glutamate transporter 2 expression in the ventral tegmental area of outbred male rats following exposure to nicotine and alcohol.
Vglut2
alcohol
brain
expression
nicotine
Journal
Drug and alcohol dependence reports
ISSN: 2772-7246
Titre abrégé: Drug Alcohol Depend Rep
Pays: Netherlands
ID NLM: 9918350383506676
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
10
03
2023
revised:
30
06
2023
accepted:
11
07
2023
medline:
3
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Initiation of use/co-use of nicotine and alcohol, commonly occurring in an episodic manner during adolescence, can imprint vulnerability to the developing brain and lead to addiction. The ventral tegmental area (VTA) is a key heterogeneous region of the mesocorticolimbic circuit involved in the binge-drinking and intoxication step of the addiction circuit. Higher human post-mortem VTA expression of The present study aimed to map and characterize the The profile of neurons varied with substance-exposure among VTA subregions. VTA
Sections du résumé
Background
UNASSIGNED
Initiation of use/co-use of nicotine and alcohol, commonly occurring in an episodic manner during adolescence, can imprint vulnerability to the developing brain and lead to addiction. The ventral tegmental area (VTA) is a key heterogeneous region of the mesocorticolimbic circuit involved in the binge-drinking and intoxication step of the addiction circuit. Higher human post-mortem VTA expression of
Methods
UNASSIGNED
The present study aimed to map and characterize the
Results
UNASSIGNED
The profile of neurons varied with substance-exposure among VTA subregions.
Conclusions
UNASSIGNED
VTA
Identifiants
pubmed: 37533815
doi: 10.1016/j.dadr.2023.100180
pii: S2772-7246(23)00050-1
pmc: PMC10391930
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100180Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Pharmacol Rev. 2016 Apr;68(2):242-63
pubmed: 26772794
Pharmacol Ther. 2020 Feb;206:107431
pubmed: 31706976
J Neurosci. 2015 Dec 2;35(48):15948-54
pubmed: 26631475
Neuroscience. 2014 Dec 12;282:60-8
pubmed: 24875175
Nat Rev Neurosci. 2011 Apr;12(4):204-16
pubmed: 21415847
Nat Neurosci. 2016 May;19(5):725-733
pubmed: 27019014
Nat Rev Neurosci. 2017 Feb;18(2):73-85
pubmed: 28053327
Front Neural Circuits. 2021 May 19;15:665386
pubmed: 34093138
Addiction. 2010 Dec;105 Suppl 1:46-54
pubmed: 21059136
Neuron. 2010 Mar 11;65(5):643-56
pubmed: 20223200
Cell Rep. 2018 May 22;23(8):2236-2244
pubmed: 29791835
J Histochem Cytochem. 1975 Jan;23(1):1-12
pubmed: 234988
Neuroscience. 2014 Dec 12;282:198-216
pubmed: 25241061
Alcohol Clin Exp Res. 2008 Dec;32(12):2081-7
pubmed: 18828805
Am J Public Health. 2007 Nov;97(11):1981-91
pubmed: 17666709
J Clin Med. 2019 Nov 06;8(11):
pubmed: 31698743
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
Eur Child Adolesc Psychiatry. 2019 Oct;28(10):1329-1340
pubmed: 30805764
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):445-60
pubmed: 27338966
Biol Psychiatry. 2019 Sep 1;86(5):344-355
pubmed: 31202491
Psychopharmacology (Berl). 2015 Feb;232(3):639-49
pubmed: 25155311
Alcohol Clin Exp Res. 1999 Mar;23(3):439-45
pubmed: 10195816
Alcohol. 2014 May;48(3):243-52
pubmed: 24721195
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):389-94
pubmed: 20018672
Tob Control. 2016 Jul;25(4):444-50
pubmed: 26063608
J Neurosci. 2014 Oct 15;34(42):13906-10
pubmed: 25319687
J Pharmacol Exp Ther. 2008 Jul;326(1):76-82
pubmed: 18369179
Front Neural Circuits. 2018 Aug 29;12:64
pubmed: 30210305
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
pubmed: 2899326
Hum Mol Genet. 2008 Jan 1;17(1):38-51
pubmed: 17928304
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
J Neurosci. 2011 Aug 31;31(35):12593-603
pubmed: 21880920
J Neurosci. 2008 Jan 2;28(1):264-78
pubmed: 18171944
J Comp Neurol. 2006 Oct 10;498(5):581-92
pubmed: 16917821
Alcohol Clin Exp Res. 2008 Dec;32(12):2149-60
pubmed: 18828796
Psychiatry Res. 2014 Oct 30;219(2):403-5
pubmed: 24953423
J Neurosci. 2009 Feb 18;29(7):2238-51
pubmed: 19228977
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12304-8
pubmed: 8618890
Eur J Neurosci. 2007 Jan;25(1):106-18
pubmed: 17241272
eNeuro. 2019 Jun 12;6(3):
pubmed: 31097625
Psychopharmacology (Berl). 2019 Jun;236(6):1887-1900
pubmed: 30758525
Brain Res Rev. 2007 Nov;56(1):27-78
pubmed: 17574681
iScience. 2018 Apr 27;2:51-62
pubmed: 29888759
J Neurosci. 2013 Mar 6;33(10):4434-55
pubmed: 23467360
J Neurosci. 2004 Dec 15;24(50):11244-52
pubmed: 15601930
Front Neurosci. 2015 Nov 05;9:404
pubmed: 26594139
Addict Biol. 2006 Mar;11(1):2-38
pubmed: 16759333
Neuron. 2017 Aug 30;95(5):1074-1088.e7
pubmed: 28823729
Addict Biol. 2017 Mar;22(2):369-380
pubmed: 26610727
Curr Addict Rep. 2017;4(1):25-34
pubmed: 28357192
Prog Brain Res. 2014;211:141-64
pubmed: 24968779
Neurochem Int. 2019 Oct;129:104482
pubmed: 31170424
Neuron. 2001 Aug 2;31(2):247-60
pubmed: 11502256
Eur J Pharmacol. 2007 Jan 26;555(2-3):139-47
pubmed: 17141214
Pharmacol Rev. 2021 Jan;73(1):163-201
pubmed: 33318153
J Neurosci. 2011 Jun 8;31(23):8476-90
pubmed: 21653852
Alcohol Res Health. 2006;29(3):186-92
pubmed: 17373407
Genome Biol. 2006;7(10):R100
pubmed: 17076895